Results from Pan et al. (2006) and our previous study demonstrated that EBP50 can suppress breast cancer cell proliferation (Zheng et al. 2010b); but, its regulatory effects on EGFR signaling in breast cancer cells remains unknown. Here, EGFR is linked to breast carcinoma.